Gene editing plus ultrasound eradicate aggressive liver cancer in mice
Cancer Liver cancer Hepatocellular Carcioma

Gene editing plus ultrasound eradicate aggressive liver cancer in mice

Dr. Abdulaziz Aldayel
Dr. Abdulaziz Aldayel

In 10 seconds? Scientists have used CRISPR/Cas9 gene-editing technology and nanoparticles to make cancer cells sensitive to a therapy that shrunk liver cancer in test animals.

What did they do? They’ve combined the gene-editing technology with a form of targeted radiation therapy knowns as Sonodynamic therapy to stop one of the most aggressive cancers worldwide, Hepatocellular carcinoma (that’s a fancy way of saying liver cancer). Sonodynamic therapy utilizes a low form of radiation in combination with drugs to release ‘reactive oxygen species’ (let’s call it ROS) at the tumor sites.

Get unlimited access to our 3-min Digests and other premium features!

Choose your plan.

Sparrow Insiders

$0 (Limited Offer)
  • Receive our daily Digest in your inbox
  • Created & reviewed by real scientists
  • Preview 380+ Digests in our library
  • Upgrade for unlimited learning
  • Unsubscribe anytime
  • Subject to availability
Join our first 25k subscribers for free! Signup Progress Bar Subscribe now for free

Sparrow Unlimited

$19 / month
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now

Sparrow Unlimited

$99 / year
  • One easy payment - save 56%
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now